MaxLinear director sells 20,747 shares; 12,141 shares remain

MaxLinear, Inc. (MXL) reported insider transactions by a director.

Accepted by SEC EDGAR 10/30/2025 - 05:14 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

MaxLinear, Inc. (MXL) reported insider transactions by a director. On 10/29/2025, the director sold 9,055 shares of common stock at $15.8693. On 10/30/2025, the director sold 20,747 shares at a $15.3928 weighted-average price, with underlying trades between $15.39 and $15.415. Following these sales, the director held 12,141 shares directly.

Insider Trade Summary

Net Seller: 29,802 shares

Net Sell 2 txns

Insider ARTUSI DANIEL A

Role Director

Sold 29,802 shs ($463K)

Type	Security	Shares	Price	Value
Sale	Common Stock	20,747	$15.3928	$319K
Sale	Common Stock	9,055	$15.8693	$144K

Holdings After Transaction: Common Stock — 12,141 shares (Direct)

Footnotes (1)

1. F1. Represents the weighted average share price of an aggregate total of 20,747 shares sold in the price range of $15.39 to $15.415 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did MXL disclose on Form 4?

A director sold 9,055 shares on 10/29/2025 at $15.8693 and 20,747 shares on 10/30/2025 at a $15.3928 weighted-average price.

What was the price range for the 20,747 MXL shares sold?

The filing states trades occurred between $15.39 and $15.415.

How many MXL shares does the director hold after these transactions?

The director beneficially owns 12,141 shares directly after the reported transactions.

What is the insider’s relationship to MaxLinear (MXL)?

The reporting person is a Director of MaxLinear, Inc.

Were the sales made under a Rule 10b5-1 trading plan?

The excerpt includes the 10b5-1(c) checkbox language, but it does not indicate whether it was checked.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ARTUSI DANIEL A

(Last) (First) (Middle)

C/O MAXLINEAR, INC.

5966 LA PLACE COURT, SUITE 100

(Street)

CARLSBAD CA 92008

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MAXLINEAR, INC [ MXL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/29/2025		S		9,055	D	$15.8693	32,888	D
Common Stock	10/30/2025		S		20,747	D	$15.3928(1)	12,141	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the weighted average share price of an aggregate total of 20,747 shares sold in the price range of $15.39 to $15.415 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Remarks:

	/s/ Connie Kwong, as Attorney-in-Fact	10/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.